OP0241 Efficacy of tocilizumab in takayasu arteritis: multicenter french retrospective study of 46 patients

Background Objectives We report the long term outcome of 46 TA patients treated with tocilizumab, describe the factors of response and compare the vascular event free survival to DMARDs. Methods retrospective nationwide french study Results We observed a decrease in the NIH scale; in C-reactive protein levels and in daily prednisone dose at 3 and 6 months, respectively; p Conclusions This nationwide study shows that tocilizumab may reduce the incidence of vascular complications in TA. Disclosure of Interest None declared